[1] Fluckiger M. Vorkommen von trommelschlagel-formigen Fingerend-phalangen ohne chronische Veranderungen an den Lungen oder am Herzen. Wien. med. Wchnschr. 1884;34:1457.

[2] Gilbert A, Fournier L. La cirrhose hypertrophique avecictère chez les enfants. Compt. rend. Soc. de biol.1895;2:419.

[3] Hijmans van den Bergh AA. Osteo-arthropathie hypertrophiantc bij hypertrophische levercirrhose. Nederl.tijdschr. v. geneesk. 1901;317:761-766.

[4] Evans PR. Section for study of disease in children: biliary cirrhosis with cyanosis and fnger-clubbing. Proc.Roy. Soc. Med. 1937;30:406-409.

[5] Snell AM. Effects of chronic disease of liver on composition and physicochemical properties of blood:changes in serum proteins: reduction in oxygen saturation of arterial blood. Ann. Int. Med. 1935;9:690-711.

[6] Keys A, Snell AM. Respiratory properties of arterial blood in normal man and in patients with disease of liver: position of oxygen dissociation curve. J. Clin. Investigation. 1938;17:59-67.

[7] Darling RC. Arterial oxygen saturation in cirrhosis of liver. Ann. Int. Med. 1940;14:898-902.

[8] wilson RH, et al. Determinations of blood fow through nonventilated portions of normal and diseased lung.Am. Rev. Tuberc. 1953;68:177-187.

[9] Rydell R, Hoffbauer FW. Multiple pulmonary arteriovenous fstulas in juvenile cirrhosis. Am. J. Med. 1956;21:450-460.

[10] Murray JF, Dawson AM, Sherlock S. Circulatory changes in chronic liver disease. Am. J. Med. 1958;24:358-367.

[11] Rodman T, Hurwitz JK, Pastor BH, Close HP. Cyanosis, clubbing and arterial oxygen unsaturation associated with Laënnec's cirrhosis. Am. J. M. Sc. 1959;238:534-541.

[12] Heinemann HO, Emirgil G, Mijnssen JP. Hyperventilation and arterial hypoxemia in cirrhosis of liver. Am J Med. 1960;28:239-246.

[13] Rodman T, Sobel M, Close HP. Arterial oxygen unsaturation and ventilation-perfusion defect of Laënnec's cirrhosis. N Engl J Med. 1960;263:73-77.

[14] Blackburn CRB, et al. Veno-arterial shunting of blood in chronic liver disease. Australasian Ann Med.1960;9:204-208.

[15] Williams MH, Jr. Hypoxemia due to venous admixture in cirrhosis of liver. J Appl Physiol. 1960;15:253.

[16] Georg J, Tygstrup N, Mellemgaard K, Winkler K. Veno-arterial shunts in cirrhosis of liver. Lancet.1960;1:852-854.

[17] Bashour FA, Miller WF, Chapman CB. Pulmonary venoarterial shunting in hepatic cirrhosis: including case with cirsoid aneurysm of thoracic wall. Am Heart J. 1961;62:350-358.

[18] Abelmann WH, Kramer GE, Verstraeten JM, Gravallese MA, Jr., McNeely WF. Cirrhosis of liver and decreased arterial oxygen saturation. Arch Int Med. 1961;108:34-40.

[19] Snell RE, Luchsinger PC. Relation of arterial hypoxaemin to hyperventilation of chronic liver disease. Am J M Sc. 1963;245:289-292.

[20] Caldwell PRB, Fritts HW, Jr., Cournand A. Oxyhemoglobin dissociation curve in liver disease. J Appl Physiol 1965;20:316-320.

[21] Kennedy TC, Knudson RJ. Exercise-aggravated hypoxemia and orthodeoxia in cirrhosis. Chest.1977;72:305-309.

[22] Buist AS, Ross BB. Predicted values for closing volumes using a modifed single breath nitrogen test. Am Rev Respir Dis. 1973;107:744-752.

[23] Krowka MJ, Cortese DA. Hepatopulmonary syndrome. Chest. 1990;98:1053-1054.

[24] H. VTD, R. SR, B. GJ, Jr SBW, S. I, E. ST. Medical aspects of liver transplantation. Hepatology. 1984;4(suppl):79-83.

[25] Maddrey WC, Van Thiel DH. Liver transplantation: an overview. Hepatology. 1988;8:948-959.

[26] Stoller JK, Moodie D, Schiavone WA et al. Reduction of intrapulmonary shunt and resolution of digital clubbing associated with primary biliary cirrhosis after liver transplantation. Hepatology. 1990;11:54-58.

[27] Mokhashi MS. Hypoxaemia-think of the liver! Every internist should be aware of the hepatopulmonary syndrome. Postgrad Med J. 1999;75:295-297.

[28] Molleston JP, Kaufman BA, Cohen A et al. Brain abscess in hepatopulmonary syndrome. J Pediatr Gastroenterol Nutr. 1999;29:225-226.

[29] Alonso Martinez JL, Zozaya Urmeneta JM, Gutierrez Dubois J, Abinzano Guillen ML, Urbieta Echezarreta MA, Anniccherico Sanchez FJ. [Prognostic signifcance of the hepatopulmonary syndrome in liver cirrhosis].Med Clin (Barc). 2006;127:133-135.

[30] Mellemgaard K, Winkler K, Tygstrup N, Georg J. Sources of venoarterial admixture in portal hypertension.J Clin Investigation. 1963;42:1399-1405.

[31] Fritts HW, Jr., Hardewig A, Rochester DF, Durand J, Cournand A. Estimation of pulmonary arteriovenous shunt-fow using intravenous injection of T-1824 dye and Kr85. J Clin Investigation. 1960;39:1841-1850.

[32] Calabresi P, Abelmann WH. Porto-caval and porto-pulmoanry anastomoses in Laënnec's cirrhosis and in heart failure. J Clin Investigation. 1957;36:1257-1266.

[33] Shaldon S, Caesar J, Chiandussi L, et al. Demontration of porta-pulmonary anastomoses in portal cirrhosis with use of radioactive krypton (Kr85). N Engl J Med. 1961;265:410-414.

[34] Nakamura T. Measurement of blood fow through portopulmonary anastomosis in portal hypertension. J Lab Clin Med. 1965;65:114-121.

[35] Berthelot P, Walker JG, Sherlock S, Reid L. Arterial changes in the lungs in cirrhosis of the liver--lung spider nevi. N Engl J Med. 1966;274:291-298.

[36] Schraufnagel DE, Malik R, Goel V, Ohara N, Chang SW. Lung capillary changes in hepatic cirrhosis in rats.Am J Physiol. 1997;272:L139-147.

[37] Zhang J, Luo B, Tang L et al. Pulmonary angiogenesis in a rat model of hepatopulmonary syndrome.Gastroenterology. 2009;136:1070-1080.

[38] Zhang JL, Yang WL, Luo B, Hu BQ, Maheshwari A, Fallon MB. The role of CX(3)CL1/CX(3) CR1 in pulmonary angiogenesis and intravascular monocyte accumulation in rat experimental hepatopulmonary syndrome. J Hepatol. 2012;57:752-758.

[39] Raevens S, Coulon S, Van Steenkiste C et al. Role of angiogenic factors/cell adhesion markers in serum of cirrhotic patients with hepatopulmonary syndrome. Liver Int. 2014.

[40] Thenappan T, Goel A, Marsboom G et al. A Central Role for CD68(+) Macrophages in Hepatopulmonary Syndrome Reversal by Macrophage Depletion. Am J Respir Crit Care Med. 2011;183:1080-1091.

[41] Mal H, Burgiere O, Durand F, Fartoukh M, Cohen-Solal A, Fournier M. Pulmonary hypertension following hepatopulmonary syndrome in a patient with cirrhosis. J Hepatol. 1999;31:360-364.

[42] Martinez-Palli G, Barbera JA, Taura P, Cirera I, Visa J, Rodriguez-Roisin R. Severe portopulmonary hypertension after liver transplantation in a patient with preexisting hepatopulmonary syndrome. J Hepatol.1999;31:1075-1079.

[43] Zhang J, Fallon MB. Hepatopulmonary syndrome: update on pathogenesis and clinical features. Nat Rev Gastroenterol Hepatol. 2012;9:539-549.

[44] Chang SW, Ohara N. Pulmonary circulatory dysfunction in rats with biliary cirrhosis. An animal model of the hepatopulmonary syndrome. Am Rev Respir Dis. 1992;145:798-805.

[45] Fallon MB, Abrams GA, McGrath JW, Hou Z, Luo B. Common bile duct ligation in the rat: a model of intrapulmonary vasodilatation and hepatopulmonary syndrome. Am J Physiol. 1997;272:G779-84.

[46] Yang Y, Chen B, Chen Y, Zu B, Yi B, Lu K. A comparison of two common bile duct ligation methods to establish hepatopulmonary syndrome animal models. Lab Anim. 2015;49:71-79.

[47] Zhang HY, Han DW, Zhao ZF et al. Multiple pathogenic factor-induced complications of cirrhosis in rats: a new model of hepatopulmonary syndrome with intestinal endotoxemia. World J Gastroenterol.2007;13:3500-3507.

[48] Zhang ZJ, Qi XL, Li ZW et al. Hepatopulmonary syndrome: the role of intra-abdominal hypertension and a novel mouse model. Int J Clin Exp Pathol. 2014;7:768-773.

[49] Krowka MJ, Wiseman GA, Burnett OL et al. Hepatopulmonary syndrome: a prospective study of relationships between severity of liver disease, PaO(2) response to 100% oxygen, and brain uptake after (99m)Tc MAA lung scanning. Chest. 2000;118:615-624.

[50] Crary GS, Burke BA, Alford BA, du Cret RP, Wood BP. Radiological cases of the month. Pulmonary arteriovenous shunting in a child with cirrhosis of the liver. Am J Dis Child. 1989;143:749-751.

[51] Schenk P, Fuhrmann V, Madl C et al. Hepatopulmonary syndrome: prevalence and predictive value of various cut offs for arterial oxygenation and their clinical consequences. Gut. 2002;51:853-859.

[52] Gupta D, Vijaya DR, Gupta R et al. Prevalence of hepatopulmonary syndrome in cirrhosis and extrahepatic portal venous obstruction. Am J Gastroenterol. 2001;96:3395-3399.

[53] Rodriguez-Roisin R, Krowka MJ. Hepatopulmonary syndrome--a liver-induced lung vascular disorder. N Engl J Med. 2008;358:2378-2387.

[54] Schenk P, Schoniger-Hekele M, Fuhrmann V, Madl C, Silberhumer G, Muller C. Prognostic signifcance of the hepatopulmonary syndrome in patients with cirrhosis. Gastroenterology. 2003;125:1042-1052.

[55] De BK, Sen S, Biswas PK, Biswas J, Maity AK. Clinical and haemodynamic aspects of hepatopulmonary syndrome in Indian patients with cirrhosis. J Gastroenterol Hepatol. 2000;15:412-416.

[56] De BK, Sen S, Biswas PK et al. Occurrence of hepatopulmonary syndrome in Budd-Chiari syndrome and the role of venous decompression. Gastroenterology. 2002;122:897-903.

[57] Mahmoodi E, Kianifar HR, Partovi S, Mafnejad S, Bozorgnia A. Intrapulmonary arteriovenous shunt in children with chronic liver disease: clinical features, laboratory data and outcome. Indian J Gastroenterol.2008;27:16-18.

[58] Noli K, Solomon M, Golding F, Charron M, Ling SC. Prevalence of hepatopulmonary syndrome in children.Pediatrics. 2008;121:e522-e527.

[59] Kim JS, Kim KM, Ko JK, Lee YJ, Lee SG. Intrapulmonary shunt in the course of pediatric liver transplantation. Transplant Proc. 2008;40:2512-2514.

[60] Tumgor G, Arikan C, Yuksekkaya HA et al. Childhood cirrhosis, hepatopulmonary syndrome and liver transplantation. Pediatr Transplant. 2008;12:353-7.

[61] Barbe T, Losay J, Grimon G et al. Pulmonary arteriovenous shunting in children with liver disease. J Pediatr.1995;126:571-9.

[62] Whitworth JR, Ivy DD, Gralla J, Narkewicz MR, Sokol RJ. Pulmonary vascular complications in asymptomatic children with portal hypertension. J Pediatr Gastroenterol Nutr. 2009;49:607-12.

[63] Anand AC, Mukherjee D, Rao KS, Seth AK. Hepatopulmonary syndrome: prevalence and clinical profle.Indian J Gastroenterol. 2001;20:24-7.

[64] Ginies JL, Couetil JP, Houssin D, Guillemain R, Champion G, Bernard O. Hepatopulmonary syndrome in a child with cystic fbrosis. J Pediatr Gastroenterol Nutr. 1996;23:497-500.

[65] Al-Moamary M, Altraif I. Hepatopulmonary syndrome associated with schistosomal liver disease. Can J Gastroenterol. 1997;11:449-450.

[66] Kim JH, Park CH, Pai MS, Hahn MH, Kim HJ. Hepatopulmonary syndrome in Gaucher disease with rightto-left shunt: evaluation and measurement using Tc-99m MAA. Clin Nucl Med. 1999;24:164-166.

[67] Griese M, Bender-Gotze C. Hepatopulmonary syndrome after allogeneic bone marrow transplantation. Bone Marrow Transplant. 1999;24:1249-1252.

[68] Teuber G, Teupe C, Dietrich CF, Caspary WF, Buhl R, Zeuzem S. Pulmonary dysfunction in non-cirrhotic patients with chronic viral hepatitis. Eur J Intern Med. 2002;13:311-318.

[69] Kaymakoglu S, Kahraman T, Kudat H et al. Hepatopulmonary syndrome in noncirrhotic portal hypertensive patients. Dig Dis Sci. 2003;48:556-560.

[70] Babbs C, Warnes TW, Haboubi NY. Non-cirrhotic portal hypertension with hypoxaemia. Gut. 1988;29:129-131.

[71] Fuhrmann V, Madl C, Mueller C et al. Hepatopulmonary syndrome in patients with hypoxic hepatitis.Gastroenterology. 2006;131:69-75.

[72] Regev A, Yeshurun M, Rodriguez M et al. Transient hepatopulmonary syndrome in a patient with acute hepatitis A. J Viral Hepat. 2001;8:83-86.

[73] Zhang JL, Fallon MB. Hepatopulmonary syndrome: update on pathogenesis and clinical features. Nature Reviews Gastroenterology & Hepatology. 2012;9:539-549.

[74] Roberts DN, Arguedas MR, Fallon MB. Cost-effectiveness of screening for hepatopulmonary syndrome in liver transplant candidates. Liver Transpl. 2007;13:206-214.

[75] Kochar R, Tanikella R, Fallon MB. Serial pulse oximetry in hepatopulmonary syndrome. Dig Dis Sci.2011;56:1862-1868.

[76] Kochar R, Tanikella R, Meleth S, Kuo HC, Wille KM, Fallon MB. Serial Pulse Oximetry in Hepatopulmonary Syndrome. Gastroenterology. 2009;136:A826-A826.

[77] Lv Y, Fan D. Hepatopulmonary Syndrome. Dig Dis Sci. 2015.

[78] Fischer CH, Campos O, Fernandes WB et al. Role of contrast-enhanced transesophageal echocardiography for detection of and scoring intrapulmonary vascular dilatation. Echocardiography. 2010;27:1233-1237.

[79] Hosono M, Machida K, Honda N et al. Quantitative lung perfusion scintigraphy and detection of intrapulmonary shunt in liver cirrhosis. Ann Nucl Med. 2002;16:577-581.

[80] Abrams GA, Nanda NC, Dubovsky EV, Krowka MJ, Fallon MB. Use of macroaggregated albumin lung perfusion scan to diagnose hepatopulmonary syndrome: a new approach. Gastroenterology. 1998;114:305-310.

[81] Abrams GA, Jaffe CC, Hoffer PB, Binder HJ, Fallon MB. Diagnostic utility of contrast echocardiography and lung perfusion scan in patients with hepatopulmonary syndrome. Gastroenterology. 1995;109:1283-1288.

[82] Koksal D, Kacar S, Koksal AS et al. Evaluation of intrapulmonary vascular dilatations with high-resolution computed thorax tomography in patients with hepatopulmonary syndrome. J Clin Gastroenterol. 2006;40:77-83.

[83] Suga K, Kawakami Y, Iwanaga H, Tokuda O, Matsunaga N. Findings of hepatopulmonary syndrome on breath-hold perfusion SPECT-CT fusion images. Ann Nucl Med. 2009;23:413-419.

[84] Iqbal CW, Krowka MJ, Pham TH, Freese DK, El Youssef M, Ishitani MB. Liver transplantation for pulmonary vascular complications of pediatric end-stage liver disease. J Pediatr Surg. 2008;43:1813-1820.

[85] Krug S, Seyfarth HJ, Hagendorff A, Wirtz H. Inhaled iloprost for hepatopulmonary syndrome: improvement of hyproxemia. Eur J Gastroenterol Hepatol. 2007;19:1140-1143.

[86] Lau EMT, McCaughan G, Torzillo PJ. Improvement in Hepatopulmonary Syndrome After Methadone Withdrawal: A Case Report with Implications for Disease Mechanism. Liver Transplantation. 2010;16:870-873.

[87] Paramesh AS, Husain SZ, Shneider B et al. Improvement of hepatopulmonary syndrome after transjugular intrahepatic portasystemic shunting: case report and review of literature. Pediatr Transplant. 2003;7:157-162.

[88] Selim KM, Akriviadis EA, Zuckerman E, Chen D, Reynolds TB. Transjugular intrahepatic portosystemic shunt: a successful treatment for hepatopulmonary syndrome. Am J Gastroenterol. 1998;93:455-458.

[89] Krowka MJ, Mandell MS, Ramsay MA et al. Hepatopulmonary syndrome and portopulmonary hypertension:a report of the multicenter liver transplant database. Liver Transpl. 2004;10:174-182.

[90] Gupta S, Castel H, Rao RV et al. Improved survival after liver transplantation in patients with hepatopulmonary syndrome. Am J Transplant. 2010;10:354-363.

[91] Motomura T, Ikegami T, Mano Y et al. Living donor liver transplantation for end-stage liver disease with severe hepatopulmonary syndrome: report of a case. Surg Today. 2011;41:436-440.

[92] Chen KF, Li B. Reversal of Severe Hepatopulmonary Syndrome in Chronic Hepatic Cirrhosis by Living Donor Liver Transplantation: Report of Two Cases. Surg Today. 2011;41:441-443.

[93] Krowka MJ, Porayko MK, Plevak DJ et al. Hepatopulmonary syndrome with progressive hypoxemia as an indication for liver transplantation: case reports and literature review. Mayo Clin Proc. 1997;72:44-53.

[94] Rolla G, Brussino L, Bucca C. The hepatopulmonary syndrome. Forum (Genova). 1998;8:84-92.

[95] Schiller O, Avitzur Y, Kadmon G et al. Nitric oxide for post-liver-transplantation hypoxemia in pediatric hepatopulmonary syndrome: case report and review. Pediatr Transplant. 2011;15:E130-E134.

[96] Taniai N, Onda M, Tajiri T et al. Reversal of hypoxemia by inhaled nitric oxide in a child with hepatopulmonary syndrome after living-related liver transplantation. Transplant Proc. 2002;34:2791-2792.